Public health aspects of Dengue virus infection relevant to Australia
Trine Gulholm A B and William D Rawlinson A B C D E
+ Author Affiliations
- Author Affiliations
A Serology and Virology Division, Department of Microbiology NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia
B School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia
C School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW, Australia
D School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia
E Tel: +61 2 9382 9113, Fax: +61 2 9382 9098, Email: w.rawlinson@unsw.edu.au
Microbiology Australia 38(4) 191-193 https://doi.org/10.1071/MA17066
Published: 31 October 2017
Abstract
Dengue is endemic in over 100 countries. The disease is not endemic in Australia currently, although the mosquito vector and imported cases cause sporadic outbreaks, predominantly in Queensland. The illness dengue fever causes a spectrum of disease from asymptomatic or a minor febrile illness through to a fatal disease caused by shock from plasma leakage or haemorrhage. There is currently no specific treatment for dengue. Dengue is mainly diagnosed using serology, antigen detection and PCR. Serological diagnosis of dengue can be difficult because of cross reactions with other flaviviruses. A vaccine is available and registered in Australia, however the overall efficacy is just over 50%. Surveillance, disease recognition, outbreak control and prevention of exposure are strategies used to combat dengue in Australia.
References
[1] Mustafa, M.S. et al. (2015) Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control. Med. J. Armed Forces India 71, 67–70.| Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC2MvovFSruw%3D%3D&md5=2ba6f82436a53e882feebb9c9ac48e19CAS |
[2] Burrell, C.J. et al. (2017) Fenner and White’s Medical Virology. 5th edn. Academic Press.
[3] CDC Public Health Image Library (2017). https://phil.cdc.gov/phil/details_linked.asp?pid=9261 (accessed September 2017).
[4] Centers for Disease Control and Prevention (2012) Dengue homepage. http://www.cdc.gov/dengue (accessed August 2017).
[5] Atkinson, B. et al. (2016) Detection of Zika Virus in semen. Emerg. Infect. Dis. 22, 940.
| Detection of Zika Virus in semen.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2sXjt12js7g%3D&md5=9a16e7bf067a68cd792ade5512878fd4CAS |
[6] Tai, A.Y.C. et al. (2017) Management of dengue in Australian travelers: a retrospective multicenter analysis. Med. J. Aust. 206, 295–300.
| Management of dengue in Australian travelers: a retrospective multicenter analysis.Crossref | GoogleScholarGoogle Scholar |
[7] WHO (2017) Emergencies preparedness, response. www.who.int/csr/don/19-july-2017-dengue-sri-lanka/en/ (accessed September 2017).
[8] WHO (2017) Dengue situation update Number 524. www.wpro.who.int/emerging_diseases/dengue_biweekly_20170829.pdf?ua=1 (accessed September 2017).
[9] Horstick, O. et al. (2015) Reviewing dengue: Still a neglected tropical disease? PLoS Negl. Trop. Dis. 9, e0003632.
| Reviewing dengue: Still a neglected tropical disease?Crossref | GoogleScholarGoogle Scholar |
[10] World Health Organization (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. WHO Press.
[11] Muller, D.A. et al. (2017) Clinical and laboratory diagnosis of dengue virus infection. J. Infect. Dis. 215, S89–S95.
| Clinical and laboratory diagnosis of dengue virus infection.Crossref | GoogleScholarGoogle Scholar |
[12] Australian Government, Department of Health (2016) Flavivirus laboratory case definition. http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-phlncd-flavivirus.htm (accessed 28 August 2017).
[13] Najioullah, F. et al. (2014) Evaluation of four commercial real-time RT-PCR kits for the detection of dengue viruses in clinical samples. Virol. J. 11, 164.
| Evaluation of four commercial real-time RT-PCR kits for the detection of dengue viruses in clinical samples.Crossref | GoogleScholarGoogle Scholar |
[14] Ahmed, N.H. and Broor, S. (2014) Comparison of NS1 antigen detection ELISA, real time RT-PCR and virus isolation for rapid diagnosis of dengue infection in acute phase. J. Vector Borne Dis. 51, 194–199.
[15] Hermann, L.L. et al. (2014) Evaluation of a dengue NS1 antigen detection assay sensitivity and specificity for the diagnosis of acute dengue virus infection. PLoS Negl. Trop. Dis. 8, e3193.
| Evaluation of a dengue NS1 antigen detection assay sensitivity and specificity for the diagnosis of acute dengue virus infection.Crossref | GoogleScholarGoogle Scholar |
[16] Simmons, C.P. et al. (2012) Dengue. N. Engl. J. Med. 366, 1423–1432.
| Dengue.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XlslOrsbw%3D&md5=1776c6f38b36e398e68596511761e583CAS |
[17] Wang, S.M. and Sekaran, S.D. (2010) Evaluation of a commercial SD dengue viris NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection. J. Clin. Microbiol. 48, 2793–2797.
| Evaluation of a commercial SD dengue viris NS1 antigen capture enzyme-linked immunosorbent assay kit for early diagnosis of dengue virus infection.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXht1Omu7vM&md5=27c97369540686f110d0cf57ff3f7682CAS |
[18] NSW Health (2015) Dengue control guideline. http://www.health.nsw.gov.au/Infectious/controlguideline/Pages/dengue.aspx (accessed 28 August 2017).
[19] Sydney Morning Herald (2017) Dengue fever cases hit 20-year high in Australia. http://www.smh.com.au/national/health/dengue-fever-cases-hit-20year-high-in-australia-20170112-gtqq5b.html (accessed September 2017).
[20] Queensland Health (2015) Queensland Dengue management plan 2015–2020.
[21] Eliminate Dengue Australia (2017) Eliminate Dengue. http://www.eliminatedengue.com/australia (accessed August 2017).
[22] WHO (2017) Immunization, vaccines and biologicals. http://www.who.int/immunization/research/development/dengue_vaccines/en/ (accessed August 2017).
[23] Sanofi Pasteur (2017) Dengue vaccine registered in 18 countries. http://dengue.info/dengue-vaccine-registered-in-18-countries/ (accessed September 2017).
[24] Malisheni, M. et al. (2017) Clinical efficacy, safety, and immunogenicity of a live attenuated tetravalent dengue vaccine (CYD-TDV) in children: a systematic review with meta-analysis. Front. Immunol. 8, 863.
| Clinical efficacy, safety, and immunogenicity of a live attenuated tetravalent dengue vaccine (CYD-TDV) in children: a systematic review with meta-analysis.Crossref | GoogleScholarGoogle Scholar |
[25] Sáez-Llorens, X. et al. (2017) Safety and immunogenicity of one versus two doses of Takeda’s tetravalent dengue vaccine in children in Asia and Latin America: interim result from a phase 2, randomized, placebo-controlled study. Lancet Infect. Dis. 17, 615–625.
| Safety and immunogenicity of one versus two doses of Takeda’s tetravalent dengue vaccine in children in Asia and Latin America: interim result from a phase 2, randomized, placebo-controlled study.Crossref | GoogleScholarGoogle Scholar |
[26] Gan, C.S. et al. (2017) Sofusbovir as treatment against dengue? Chem. Biol. Drug Des. , .
| Sofusbovir as treatment against dengue?Crossref | GoogleScholarGoogle Scholar |
